Evidence map›Paper›PMID 27173097›Full record

ReviewImmunology letters2016

IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease.

Ushani Srenathan, Kathryn Steel, Leonie S Taams

Open access · hybridAbstract readReview
In one paragraph

Review in Immunology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. CD80Cell communication and signaling : CCS · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Downregulation ofeLife · 2024
    Article
  17. Downregulation ofbioRxiv : the preprint server for biology · 2024
    Article
  18. Review
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ushani SrenathanCentre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection & Inflammatory Disease, King's College London, London, UK.
Kathryn SteelCentre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection & Inflammatory Disease, King's College London, London, UK.
Leonie S TaamsCentre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection & Inflammatory Disease, King's College London, London, UK. Electronic address: leonie.taams@kcl.ac.uk.
King's College London · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

The pro-inflammatory cytokine interleukin-17A (IL-17) has been the subject of research by many groups worldwide. IL-17 expression is often associated with a specific subset of CD4+ T cells (the so-called Th17 cells); however various other immune cell subsets can also synthesise and express IL-17, including CD8+ T cells. Here we review recent data regarding the presence of IL-17+ CD8+ T cells (also known as Tc17 cells) in human inflammatory disease, discuss current knowledge regarding the culture conditions required for the differentiation of these cells in humans and mice, and describe key phenotypic and functional features. Collectively, this information may shed light on the potential pathogenic role that IL-17+ CD8+ T cells may play in human inflammatory disease.

Indexed as

AnimalsBiomarkersCD8-Positive T-LymphocytesCell DifferentiationCytokinesGene Expression RegulationHumansInflammationInflammation MediatorsInterleukin-17Lymphocyte ActivationMicePhenotypeSignal TransductionT-Lymphocyte SubsetsBiomarkersCytokinesInflammation MediatorsInterleukin-17CD8+DiseaseIL-17InflammationTc17

Identifiers

PMID27173097
PMCPMC5046976
OpenAlexW2347018476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.